Standout Papers
Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons
2020 StandoutNobel
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
2020 Science
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
2016
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
2018
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
2020
Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2′,3′ cGAMP Signaling
2015 StandoutNobel
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
RIG-I-like receptors: their regulation and roles in RNA sensing
2020
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Dicer-TRBP Complex Formation Ensures Accurate Mammalian MicroRNA Biogenesis
2014 StandoutNobel
Molecular Imprinting as a Signal-Activation Mechanism of the Viral RNA Sensor RIG-I
2014
Cytosolic Sensing of Viruses
2013
Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing
2014 StandoutNobel
COVID-19: A review of therapeutic strategies and vaccine candidates
2020
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
2021
HCV NS5A and IRF9 compete for CypA binding
2012
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
2012
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5
2012
RIG-I Forms Signaling-Competent Filaments in an ATP-Dependent, Ubiquitin-Independent Manner
2013
Immune Signaling by RIG-I-like Receptors
2011
Metazoan MicroRNAs
2018 Standout
Visualizing the Determinants of Viral RNA Recognition by Innate Immune Sensor RIG-I
2012
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
Autophagy and innate immunity: Triggering, targeting and tuning
2010
The E3-Ligase TRIM Family of Proteins Regulates Signaling Pathways Triggered by Innate Immune Pattern-Recognition Receptors
2013
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Virus-host protein interactions in RNA viruses
2010
Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
2011
Innate Immune Receptors
2016
Autophagy in immunity and inflammation
2011 StandoutNature
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
SARS-CoV-2 vaccines in development
2020 StandoutNature
ATP-Dependent Effector-like Functions of RIG-I-like Receptors
2015 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP)
2019 StandoutNobel
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition
2011
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
2014
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
ATP-independent diffusion of double-stranded RNA binding proteins
2012 StandoutNobel
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
The Caenorhabditis elegans ARIP-4 DNA helicase couples mitochondrial surveillance to immune, detoxification, and antiviral pathways
2022 StandoutNobel
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
A Virological View of Innate Immune Recognition
2012
Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality
2014
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments
2012
Double-Stranded RNA Sensors and Modulators in Innate Immunity
2019
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
2015
Works of Alina Baum being referenced
Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing
2010
Induction of type I interferon by RNA viruses: cellular receptors and their substrates
2009
In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells
2014
ATPase‐driven oligomerization of RIG‐I on RNA allows optimal activation of type‐I interferon
2013
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
2020 Science
Differential recognition of viral RNA by RIG-I
2011